Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Angiotensin II for Post Cardiac Surgery Vasoplegia
NCT07671365Phase 4Not yet recruiting
- Sponsor
- Methodist Healthcare System of San Antonio
- Start
- Jul 2026
- Primary completion
- Jul 2029
01
Overview
A Phase 4 trial of Angiotensin II in Vasoplegia, vasoplegic shock, sponsored by Methodist Healthcare System of San Antonio. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
Angiotensin II
03
Conditions
Vasoplegiavasoplegic shock
Beyond the preview
Go deeper on NCT07671365.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07671365.